Advertisement
AME vs EMR
Which Stock Would AI Choose? AMETEK (AME) vs. Emerson Electric (EMR) Stock Comparison
Key Takeaways
- AMETEK (AME) and Emerson Electric (EMR) are both diversified industrial technology leaders, but they serve different niches and have shown diverging relative performance in recent months.
- AME has posted record results and stronger upward momentum, while EMR has navigated geopolitical headwinds that weighed on sales growth.
- Valuation differs sharply: AME trades at a premium multiple, while EMR carries a more moderate forward earnings multiple and a higher dividend yield.
- Tickeron AI Verdict: AME currently appears to hold the edge based on trend consistency, execution momentum, and relative stability.
- For more detail, explore AME Major News, AME Today's Price Move, EMR Major News, and EMR Today's Price Move.
- To see which AI trading strategies are currently favored, explore the Trending AI Robots.
Introduction
Investors evaluating the industrial technology and automation space frequently weigh AMETEK (AME) against Emerson Electric (EMR). Both companies supply precision instruments, automation hardware, and increasingly software-driven solutions to industrial, aerospace, energy, and healthcare customers, yet their business models and recent trajectories differ in meaningful ways. This stock comparison examines relative performance, market positioning, growth drivers, and risk factors to help traders and long-term investors understand which of these two names the current market environment appears to favor.
AME Overview and Recent Performance
AMETEK, Inc. (AME) is a diversified manufacturer of electronic instruments and electromechanical devices, organized around its Electronic Instruments Group (EIG) and Electromechanical Group (EMG). The company operates across niche industrial, aerospace and defense, energy, and healthcare end markets, supported by a repeatable acquisition strategy. In recent quarters, AMETEK has delivered record financial results, including record sales, orders, operating income, and a record backlog, with double-digit growth in its EMG segment and margin expansion in EIG.
Sentiment has been reinforced by a series of acquisitions, most notably the roughly $5 billion all-cash purchase of the Indicor instrumentation portfolio, alongside deals such as LKC Technologies and First Aviation Services, which broaden its aerospace, defense, and medical technology exposure. The company also raised its quarterly dividend by 10%. Shares have traded near the higher end of their 52-week range, with positive year-to-date momentum, though the stock's premium valuation—roughly 29 to 30 times earnings—reflects investor confidence that management can sustain growth and integrate recent deals without eroding margins.
EMR Overview and Recent Performance
Emerson Electric Co. (EMR) is a global automation and software leader headquartered in St. Louis, structured around its Intelligent Devices and Software and Control business groups, plus a Safety and Productivity segment. Emerson positions itself around "engineering the autonomous future," combining automation hardware with software capabilities, including its AspenTech industrial software business, to serve process, hybrid, and discrete industries.
Recent performance has been more mixed. Emerson has reported resilient underlying order growth and solid backlog expansion, led by its Software and Systems business, but its top-line sales growth has been constrained by disruptions tied to the Middle East conflict, which management cited as a headwind. In its most recent quarter, net sales rose modestly year over year but came in below some consensus estimates, while adjusted earnings per share (EPS) advanced on strong cost discipline and margin performance. Management trimmed its full-year organic sales growth outlook while maintaining a healthy adjusted EPS range and plans to return meaningful capital to shareholders through buybacks and dividends.
Trending AI Robots
For traders seeking a systematic edge, Tickeron's Trending AI Robots page offers a curated view of the platform's AI trading bots. Tickeron hosts hundreds of AI Trading Bots that trade thousands of different tickers across varied styles, strategies, timeframes, and performance profiles. Because market conditions shift, only a subset of bots is well-suited to the current environment, and the Trending AI Robots section highlights those showing the most relevant recent results. The page presents key statistics that help users assess each bot's approach and track record. Explore the Trending AI Robots page to see which automated strategies are currently capturing the market's attention.
Head-to-Head Comparison
While both AME and EMR operate in industrial technology, their models differ. AMETEK is a diversified, acquisition-driven portfolio of niche instrumentation and electromechanical businesses with broad end-market exposure and high operating margins. Emerson is a larger, more concentrated automation and software platform, with a heavier tilt toward process industries, energy, and increasingly software-centric recurring revenue.
Growth drivers also contrast. AMETEK's momentum has been supported by organic growth, margin expansion, and accretive acquisitions, while Emerson's growth leans on software and systems demand, power and life sciences verticals, and a robust backlog—though it has faced near-term geopolitical friction. On risk, AMETEK carries integration and valuation risk given its premium multiple, whereas Emerson faces exposure to regional conflicts and software execution dynamics. Sentiment has favored AMETEK in recent months, reflected in stronger relative price performance and more consistent earnings beats.
Tickeron AI Verdict
Based on observable factors such as trend consistency, execution momentum, stability, and relative positioning, Tickeron's AI currently appears to favor AME over EMR. AMETEK's record results, steady margin expansion, diverse end-market exposure, and stronger recent momentum stand in contrast to Emerson's sales headwinds and softer top-line growth, even though Emerson offers a more moderate valuation and higher dividend yield. This is a probabilistic assessment grounded in current data, not a guarantee of future returns, and it may shift as new earnings and market conditions emerge.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AME is a Hold and EMR is a Buy.
AME's RSI Oscillator climbs out of oversold territory
The RSI Oscillator for AME moved out of oversold territory on November 06, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 21 similar instances when the indicator left oversold territory. In 17 of the 21 cases the stock moved higher. This puts the odds of a move higher at 81%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 35 of 52 cases where AME's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 67%.
Following a +4.22% 3-day Advance, the price is estimated to grow further. Considering data from situations where AME advanced for three days, in 162 of 329 cases, the price rose further within the following month. The odds of a continued upward trend are 49%.
AME may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on November 04, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on AME as a result. In 39 of 89 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 44%.
The Moving Average Convergence Divergence Histogram (MACD) for AME turned negative on October 14, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In 17 of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at 38%.
AME moved below its 50-day moving average on November 04, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for AME crossed bearishly below the 50-day moving average on November 05, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 5 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 31%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AME declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 45%.
The Aroon Indicator for AME entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Profit vs. Risk Rating rating for this company is 11 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 73, placing this stock better than average.
The Tickeron PE Growth Rating for this company is 35 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 55 (best 1 - 100 worst), indicating steady price growth. AME’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 58 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 84 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.656) is normal, around the industry mean (3.843). P/E Ratio (33.334) is within average values for comparable stocks, (36.971). Projected Growth (PEG Ratio) (2.859) is also within normal values, averaging (1.879). Dividend Yield (0.006) settles around the average of (0.032) among similar stocks. P/S Ratio (6.803) is also within normal values, averaging (189.487).
Momentum Indicator for EMR turns positive, indicating new upward trend
EMR saw its Momentum Indicator move above the 0 level on October 27, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 91 similar instances where the indicator turned positive. In 58 of the 91 cases, the stock moved higher in the following days. The odds of a move higher are at 64%.
Technical Analysis (Indicators)
Bullish Trend Analysis
Following a +2.70% 3-day Advance, the price is estimated to grow further. Considering data from situations where EMR advanced for three days, in 219 of 345 cases, the price rose further within the following month. The odds of a continued upward trend are 63%.
The Aroon Indicator entered an Uptrend today. In 156 of 274 cases where EMR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 57%.
Bearish Trend Analysis
The 10-day RSI Indicator for EMR moved out of overbought territory on October 30, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 42 similar instances where the indicator moved out of overbought territory. In 20 of the 42 cases, the stock moved lower in the following days. This puts the odds of a move lower at 48%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 37 of 60 cases where EMR's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 62%.
The Moving Average Convergence Divergence Histogram (MACD) for EMR turned negative on November 05, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In 25 of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at 57%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where EMR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 56%.
EMR broke above its upper Bollinger Band on October 27, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Profit vs. Risk Rating rating for this company is 16 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 73, placing this stock better than average.
The Tickeron Price Growth Rating for this company is 27 (best 1 - 100 worst), indicating outstanding price growth. EMR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 32 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 62 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 81 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.444) is normal, around the industry mean (3.843). P/E Ratio (35.370) is within average values for comparable stocks, (36.971). Projected Growth (PEG Ratio) (1.837) is also within normal values, averaging (1.879). Dividend Yield (0.014) settles around the average of (0.032) among similar stocks. P/S Ratio (4.409) is also within normal values, averaging (189.487).
AME | EMR | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 39 | 30 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 84 Overvalued | 81 Overvalued | |
PROFIT vs RISK RATING 1..100 | 11 | 16 | |
SMR RATING 1..100 | 58 | 62 | |
PRICE GROWTH RATING 1..100 | 55 | 27 | |
P/E GROWTH RATING 1..100 | 35 | 32 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
EMR's Valuation (81) in the Electrical Products industry is in the same range as AME (84) in the Miscellaneous Manufacturing industry. This means that EMR’s stock grew similarly to AME’s over the last 12 months.
AME's Profit vs Risk Rating (11) in the Miscellaneous Manufacturing industry is in the same range as EMR (16) in the Electrical Products industry. This means that AME’s stock grew similarly to EMR’s over the last 12 months.
AME's SMR Rating (58) in the Miscellaneous Manufacturing industry is in the same range as EMR (62) in the Electrical Products industry. This means that AME’s stock grew similarly to EMR’s over the last 12 months.
EMR's Price Growth Rating (27) in the Electrical Products industry is in the same range as AME (55) in the Miscellaneous Manufacturing industry. This means that EMR’s stock grew similarly to AME’s over the last 12 months.
EMR's P/E Growth Rating (32) in the Electrical Products industry is in the same range as AME (35) in the Miscellaneous Manufacturing industry. This means that EMR’s stock grew similarly to AME’s over the last 12 months.
| AME | EMR | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 81% | 2 days ago 48% |
| Stochastic ODDS (%) | 2 days ago 67% | 2 days ago 62% |
| Momentum ODDS (%) | 2 days ago 44% | 2 days ago 64% |
| MACD ODDS (%) | 2 days ago 38% | 2 days ago 57% |
| TrendWeek ODDS (%) | 2 days ago 45% | 2 days ago 62% |
| TrendMonth ODDS (%) | 2 days ago 45% | 2 days ago 56% |
| Advances ODDS (%) | 2 days ago 49% | 8 days ago 63% |
| Declines ODDS (%) | 7 days ago 45% | 6 days ago 56% |
| BollingerBands ODDS (%) | 2 days ago 64% | 2 days ago 57% |
| Aroon ODDS (%) | 2 days ago 51% | 2 days ago 57% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
AME’s FA Score shows that 1 FA rating(s) are green while EMR’s FA Score has 3 green FA rating(s).
- AME’s FA Score: 1 green, 4 red.
- EMR’s FA Score: 3 green, 2 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
AME’s TA Score shows that 4 TA indicator(s) are bullish while EMR’s TA Score has 3 bullish TA indicator(s).
- AME’s TA Score: 4 bullish, 6 bearish.
- EMR’s TA Score: 3 bullish, 5 bearish.
Price Growth
AME (@Industrial Machinery) experienced а -4.13% price change this week, while EMR (@Industrial Machinery) price change was +0.69% for the same time period.
The average weekly price growth across all stocks in the @Industrial Machinery industry was +2.87%. For the same industry, the average monthly price growth was -8.89%, and the average quarterly price growth was -16.20%.
Reported Earning Dates
AME is expected to report earnings on Feb 04, 2027.
EMR is expected to report earnings on Feb 10, 2027.
Industries' Descriptions
@Industrial Machinery (+2.87% weekly)The industry makes and maintains machines for consumers, the industry, and most other companies. While it has traditionally been categorized as heavy industry, some smaller companies are also branching into the light category. The industry is pivotal in providing the equipment for production in businesses like agriculture, mining, industry and construction, gas, electricity and water utilities. It also supplies supporting equipment for almost all sectors of the economy, such as equipment for heating, and air conditioning of buildings. Illinois Tool Works Inc., Parker-Hannifin Corporation and Rockwell Automation Inc are some of the major U.S. companies operating in this industry.
Advertisement
EMR and
Correlation & Price change
A.I.dvisor indicates that over the last year, EMR has been closely correlated with AME. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if EMR jumps, then AME could also see price increases.